The Ex-Regulator's View On Small Surface Contamination Control: It's Just A Bit Of Wiping, Right?
By Matt Cokely, global technical consultant strategic director, Ecolab Life Sciences, and Philip Rose, managing director and QP, Rose Pharma Solutions Ltd.

“It’s just a bit of wiping, right?” This common refrain often masks a dangerous underestimation of the crucial role small surfaces play in cleanroom contamination control. While they may seem insignificant compared to walls and floors, these ubiquitous areas – worktables, equipment consoles, transfer carts – are often in close proximity to the final drug product, making their cleanliness paramount. Matt Cokely and Philip Rose, experienced auditors of global cleanroom facilities, argue that neglecting the details of small surface disinfection is a critical error with potentially significant consequences. From product residues to microbial build-up in overlooked crevices, the devil truly is in the details.
This article challenges the casual approach to small surface disinfection, urging a shift towards rigorous, validated, and consistently applied protocols. Ready to learn more? Access the article below.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.